Got a credit card? use our Credit Card & Finance Calculators
Thanks to johnstevens77,Bhoddhisatva,scotia,Anonymous,Cornytiv34, for Donating to support the site
coronavirus shares
-
- Lemon Quarter
- Posts: 1080
- Joined: November 8th, 2016, 7:32 am
- Has thanked: 8 times
- Been thanked: 432 times
coronavirus shares
RB?
Portfolio of household cleaners (Lysol, Dettox) and OTC medicines.
Any other companies spring to mind?
BoE
Portfolio of household cleaners (Lysol, Dettox) and OTC medicines.
Any other companies spring to mind?
BoE
-
- Lemon Quarter
- Posts: 2081
- Joined: November 4th, 2016, 11:53 am
- Has thanked: 3203 times
- Been thanked: 417 times
-
- Lemon Slice
- Posts: 503
- Joined: November 8th, 2016, 6:56 pm
- Has thanked: 221 times
- Been thanked: 246 times
Re: coronavirus shares
My experience at ODX where I got very lucky has got me thinking about this whole crisis and its effect on our investing. At the moment I am positioned for a relatively short term disruption. I have been buying shares in companies that have strong balance sheets and net cash and should be well placed to ride out 6 months or so of disruption and will hopefully return to some sort of normality thereafter and thus look cheap at today's prices.
But am I correct in doing this? Is Coronavirus the new normal? Will the pubs open before Christmas and we'll all be back at work in a months time or should we be preparing for years of disruption?
But am I correct in doing this? Is Coronavirus the new normal? Will the pubs open before Christmas and we'll all be back at work in a months time or should we be preparing for years of disruption?
-
- Lemon Slice
- Posts: 325
- Joined: April 12th, 2017, 11:18 pm
- Has thanked: 56 times
- Been thanked: 125 times
Re: coronavirus shares
One idea is dipping in and out of trackers catching the zig zags for short term trader profit. Transfer tax is on many shares making those less easy to dip in and out as happily as it lops off much of the profits. It does involves a lot of work, following trends and graph reading for not that much reward, and there is always more risk of course, but still better than doing nothing to fill the empty coffers. Long term investments are good price wise, but without divis, then the money isn't doing any donkey work. So zig zag harvesting is one way.
-
- Lemon Quarter
- Posts: 4093
- Joined: November 4th, 2016, 9:24 am
- Has thanked: 3234 times
- Been thanked: 2828 times
Re: coronavirus shares
Pipsmum wrote:One idea is dipping in and out of trackers catching the zig zags for short term trader profit. Transfer tax is on many shares making those less easy to dip in and out as happily as it lops off much of the profits. It does involves a lot of work, following trends and graph reading for not that much reward, and there is always more risk of course, but still better than doing nothing to fill the empty coffers. Long term investments are good price wise, but without divis, then the money isn't doing any donkey work. So zig zag harvesting is one way.
But how do you ensure that the market doesn't zig while you zag?
--kiloran
-
- Lemon Slice
- Posts: 575
- Joined: November 11th, 2016, 12:53 pm
- Has thanked: 130 times
- Been thanked: 208 times
Re: coronavirus shares
Interestingly I Zigged yesterday morning by selling all my VMID and VWRL. Always feels funny pressing the button on what are life changing amounts of money. Need to get back in though.
It was purely a reaction to Wall Street having been up 5 of the last 6 days and a realisation that it was within 15ish% of it's all time highs. That is bonkers given what the real world is experiencing.
It was purely a reaction to Wall Street having been up 5 of the last 6 days and a realisation that it was within 15ish% of it's all time highs. That is bonkers given what the real world is experiencing.
-
- Lemon Quarter
- Posts: 2049
- Joined: November 4th, 2016, 10:32 am
- Has thanked: 5301 times
- Been thanked: 2465 times
Re: coronavirus shares
Gilead Sciences
Gilead is an American biopharmaceutical company, specialising in antiviral drugs, which until recently was best known for its treatments for HIV and Hepatitis. Nowadays it's in the news for "Remdesivir", which as I type this is the only drug that has been shown to have some effect in approved clinical trials on the Wuhan Coronavirus. From an American study, published on April 29th.
"Hospitalized patients with advanced COVID-19 and lung involvement who received remdesivir recovered faster than similar patients who received placebo, according to a preliminary data analysis from a randomized, controlled trial involving 1063 patients, which began on February 21."
https://www.niaid.nih.gov/news-events/nih-clinical-trial-shows-remdesivir-accelerates-recovery-advanced-covid-19
"The U.S. National Institutes of Health on Wednesday said preliminary results from its trial of remdesivir showed that COVID-19 patients given the drug recovered 31% faster than those given a placebo."
https://www.reuters.com/article/us-gilead-sciences-results/gilead-to-work-with-partners-to-ramp-up-production-of-potential-coronavirus-treatment-idUSKBN22C3PO
As the reports say, Remdesivir is not a "magic bullet" but it is a good to start. If it improves the speed with which patients recover then this eases the pressure on hospitals and gives them the capacity to cope with more cases. Currently Remdesivir has to be administered intravenously, though the company is working on a tablet. If Remdesivir ends up being used worldwide, Gilead doesn't have the manufacturing capacity so it has said that it will licence it to other companies who can then manufacture it.
Gilead's shares currently yield 3.2% (2.7% after American withholding tax of 15%). First quarter results were published yesterday along with it declaring an unchanged dividend. Historic price-earnings ratio of 13.4, consensus forecast P/E for 2020 is 20.
Gilead is currently my second largest shareholding. Until a couple of months ago I didn't own any shares, though it had been on my watchlist for several years. I reckon that it's a decent buy even without Remdesivir due to its existing drugs and development pipeline.
Gilead is an American biopharmaceutical company, specialising in antiviral drugs, which until recently was best known for its treatments for HIV and Hepatitis. Nowadays it's in the news for "Remdesivir", which as I type this is the only drug that has been shown to have some effect in approved clinical trials on the Wuhan Coronavirus. From an American study, published on April 29th.
"Hospitalized patients with advanced COVID-19 and lung involvement who received remdesivir recovered faster than similar patients who received placebo, according to a preliminary data analysis from a randomized, controlled trial involving 1063 patients, which began on February 21."
https://www.niaid.nih.gov/news-events/nih-clinical-trial-shows-remdesivir-accelerates-recovery-advanced-covid-19
"The U.S. National Institutes of Health on Wednesday said preliminary results from its trial of remdesivir showed that COVID-19 patients given the drug recovered 31% faster than those given a placebo."
https://www.reuters.com/article/us-gilead-sciences-results/gilead-to-work-with-partners-to-ramp-up-production-of-potential-coronavirus-treatment-idUSKBN22C3PO
As the reports say, Remdesivir is not a "magic bullet" but it is a good to start. If it improves the speed with which patients recover then this eases the pressure on hospitals and gives them the capacity to cope with more cases. Currently Remdesivir has to be administered intravenously, though the company is working on a tablet. If Remdesivir ends up being used worldwide, Gilead doesn't have the manufacturing capacity so it has said that it will licence it to other companies who can then manufacture it.
Gilead's shares currently yield 3.2% (2.7% after American withholding tax of 15%). First quarter results were published yesterday along with it declaring an unchanged dividend. Historic price-earnings ratio of 13.4, consensus forecast P/E for 2020 is 20.
Gilead is currently my second largest shareholding. Until a couple of months ago I didn't own any shares, though it had been on my watchlist for several years. I reckon that it's a decent buy even without Remdesivir due to its existing drugs and development pipeline.
-
- Lemon Slice
- Posts: 325
- Joined: April 12th, 2017, 11:18 pm
- Has thanked: 56 times
- Been thanked: 125 times
Re: coronavirus shares
kiloran wrote:But how do you ensure that the market doesn't zig while you zag?
--kiloran
It does sometimes.
Careful graph reading for catching upward trends and signs of change, then chasing up underneath with a tight stop. Doesn't always go to plan but the stop losses prevent big holes. Or by setting catch nets above and below sideways zig zags. As everything is rock bottom then down is further down and upwards very volatile.
Watch one for a while and see in theory, or practice on a test site. Can be lucrative when it's right, but very damaging when it's wrong. The trend is your friend, so stay with the flow and don't swim upstream.
-
- Lemon Slice
- Posts: 325
- Joined: April 12th, 2017, 11:18 pm
- Has thanked: 56 times
- Been thanked: 125 times
Re: coronavirus shares
Some pharmaceuticals that are interesting .
ORPH - Open Orphan. Currently @12.88p and have an inked contract for covid tests.
https://www.londonstockexchange.com/exc ... XASQ1.html
Haven't looked at these yet but
ABT - Abbott labs and ROG - Roche also are supposedly providing tests.
I presume this will be lucrative for some or all of them.
ORPH - Open Orphan. Currently @12.88p and have an inked contract for covid tests.
https://www.londonstockexchange.com/exc ... XASQ1.html
Haven't looked at these yet but
ABT - Abbott labs and ROG - Roche also are supposedly providing tests.
I presume this will be lucrative for some or all of them.
-
- Lemon Slice
- Posts: 325
- Joined: April 12th, 2017, 11:18 pm
- Has thanked: 56 times
- Been thanked: 125 times
Re: coronavirus shares
ORPH Open Orphan having a nice run today on the covid vaccine news. 15p now. I saw an estimate saying it could be 30p. Wait for a pullback I suppose. DYOR
Return to “Stocks and Share Dealing Discussions”
Who is online
Users browsing this forum: No registered users and 3 guests